Md Al Mamun Ahsan

CRISPR‐Cas9 in Cancer Therapy: Overcoming Delivery Barriers and Off‐Target Effects for Clinical Translation

It is argued that improvements in editing efficiency alone will be insufficient; clinical success will require the simultaneous achievement of tumor‐selective delivery, genomic integrity, and acceptable long‐term safety, and the continued development of novel approaches should be promoted to realize the full potential...